Matrix Accumulation in the Metastatic Niche

转移生态位中的基质积累

基本信息

  • 批准号:
    10732790
  • 负责人:
  • 金额:
    $ 8.59万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-01 至 2026-11-30
  • 项目状态:
    未结题

项目摘要

Project Summary Breast cancer (BC) is the most frequently diagnosed cancer in women. In addition, metastatic BC has a 5-year survival rate of only 27% and metastases are associated with the vast majority of cancer-related deaths. Recent research has highlighted a complex dynamic between cancer cells and the tumor microenvironment as essential for the formation of macrometastases. Within this field, tissue stiffening through matrix accumulation and altered matrix organization were recently linked with sustained proliferation and increased migration of tumor cells. Elevated levels of the glycoprotein fibronectin (FN) have been correlated to poor patient survival in BC and are linked to enhanced seeding of disseminated tumor cells at metastatic sites. My previous work has indicated several mechanisms through which accumulated FN impacts the metastatic potential of BC cells. Foremost, I helped identify a transient increase in extracellular FN in the lungs, which peaked before overt metastasis, coupled with a non-transient increase in total lung volume. I further found that cyclic mechanical force acted as a suppressor of cancer cell growth in a biomimetic lung model, implicating the accumulation of extracellular matrix (ECM) as an attempt by the cancer cells to alter the mechanical properties of the lung tissue and resist entering dormancy. However, my results showed that BC cells could not organize FN into ECM independently. Instead, BC cells altered the accumulation and architecture of FN by conditioning resident fibroblasts through soluble factors and extracellular vesicles. I observed that the FN produced by conditioned fibroblasts varied not only based on the phenotype of the BC cell, but also from the method of conditioning which tested paracrine and endocrine signaling. These preliminary results indicate that unique subtypes of cancer associated fibroblasts (CAFs) may develop based on the BC cell conditioning mechanism, where unique subtypes may be associated with the specific needs of the various stages of the metastatic cascade. Therefore, Aim 1 of the proposed studies during my Ph.D. research will define the contribution of cyclic strain on BC cell phenotype and dormancy using our novel actuating platform. Aim 2, which I will undertake during my postdoctoral research, will seek to better define the varied roles of CAFs in metastatic progression through the development of a foundation of subtypes after conditioning with media, isolated extracellular vesicles, and contact from BC cancer cells, including metastatic and non-metastatic BC cells with epithelial and mesenchymal phenotypes. These findings will enable advanced interaction studies and promote the development of novel targets for fibroblasts, which may be a more consistent target than genetically unstable cancer cells and lead to more effective treatment. In addition, the proposed studies and training plan will expand my current tissue engineering skillset to include advanced understanding of mechanotransduction pathways and CAF formation as well as improve my communication, mentoring, and teaching. Together, these skills will place me as a competitive candidate for an independent principle investigator position in a research university at the intersection of cancer biology and engineering.
项目摘要 乳腺癌(BC)是女性最常见的癌症。此外,转移性卑诗省有5年 仅27%的生存率和转移与绝大多数与癌症相关的死亡有关。最近的 研究强调了癌细胞与肿瘤微环境之间的复杂动态,这是必不可少的 用于宏观变体的形成。在该领域,组织通过基质积累僵硬并改变 基质组织最近与持续增殖和增加的肿瘤细胞迁移有关。 糖蛋白纤连蛋白(FN)的水平升高与卑诗省的患者生存率不佳相关,并且 与转移部位的散布肿瘤细胞增强的播种相关。我以前的工作已经表明 积累FN会影响BC细胞的转移潜力的几种机制。最重要的是,我 帮助确定肺部细胞外FN的短暂增加,该肺在明显转移之前达到峰值, 再加上总肺部量的非变压增加。我进一步发现,环状机械力充当 仿生肺模型中癌细胞生长的抑制剂,暗示细胞外的积累 基质(ECM)作为癌细胞的尝试改变肺组织的机械性能并抵抗 进入休眠。但是,我的结果表明,BC细胞无法独立地将FN组织到ECM中。 相反,BC单元通过调节居民成纤维细胞通过调节FN的积累和结构 可溶性因子和细胞外囊泡。我观察到由条件成纤维细胞产生的FN不变 仅基于BC细胞的表型,还基于测试旁分泌和调节方法 内分泌信号传导。这些初步结果表明,癌症相关的成纤维细胞的独特亚型 (CAFS)可能会根据BC细胞调节机制开发,其中独特的亚型可能与之相关 满足转移级联的各个阶段的特定需求。因此,拟议研究的目标1 在我的博士学位期间研究将定义循环应变对BC细胞表型和休眠的贡献 我们的新颖的驱动平台。我将在博士后研究中进行的AIM 2将寻求更好 通过开发亚型的基础来定义CAF在转移性进展中的各种作用 用培养基调节后,分离的细胞外囊泡,并从卑诗省癌细胞接触 带有上皮和间质表型的转移和非转移性BC细胞。这些发现将启用 高级相互作用研究并促进成纤维细胞的新靶标的发展,这可能是更多 一致的靶标比遗传不稳定的癌细胞,并导致更有效的治疗。另外, 拟议的研究和培训计划将扩大我当前的组织工程技能,包括高级 了解机械转导途径和CAF形成以及改善我的交流 指导和教学。这些技能在一起将使我成为独立的竞争候选人 癌症生物学与工程交集的研究大学的主要研究者职位。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sarah Libring其他文献

Sarah Libring的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sarah Libring', 18)}}的其他基金

Matrix Accumulation in the Metastatic Niche
转移生态位中的基质积累
  • 批准号:
    10475247
  • 财政年份:
    2021
  • 资助金额:
    $ 8.59万
  • 项目类别:
Matrix Accumulation in the Metastatic Niche
转移生态位中的基质积累
  • 批准号:
    10305336
  • 财政年份:
    2021
  • 资助金额:
    $ 8.59万
  • 项目类别:

相似国自然基金

HIF-2α介导Müller调节神经细胞凋亡的缺血性视网膜病变机制研究
  • 批准号:
    82371077
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
草鱼贮藏过程肌细胞凋亡对鱼肉品质的影响机制研究
  • 批准号:
    32372397
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
RIG-I/MAVS非干扰素依赖通路诱导细胞凋亡介导七鳃鳗抗病毒的机制研究
  • 批准号:
    32360150
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
SLC46A3参与铜耗竭介导的mPFC抑制性神经元坏死性凋亡在睡眠剥夺致术后痛慢性化的机制研究
  • 批准号:
    82371235
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
银鲳磷酸酶A2抑制因子(PLI)对水母毒素诱导细胞凋亡的抑制作用及机制研究
  • 批准号:
    42306114
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

UBIQUIBODY PLATFORM FOR TARGETED DEGRADATION OF ONCOGENIC FUSION PROTEINS
用于靶向降解致癌融合蛋白的 Ubiquibody 平台
  • 批准号:
    10806354
  • 财政年份:
    2023
  • 资助金额:
    $ 8.59万
  • 项目类别:
Integration of Brain and Face Morphogenesis in Normal and Disease Phenotypes
正常和疾病表型中大脑和面部形态发生的整合
  • 批准号:
    10826915
  • 财政年份:
    2023
  • 资助金额:
    $ 8.59万
  • 项目类别:
Cellular Basis of Incisor Asymmetry
门牙不对称的细胞基础
  • 批准号:
    10707930
  • 财政年份:
    2022
  • 资助金额:
    $ 8.59万
  • 项目类别:
Harnessing Continuous Liquid Interface 3D Printing to Improve Tumor-homing Stem Cell Therapy for Post-surgical Brain Cancer
利用连续液体界面 3D 打印改善脑癌术后肿瘤归巢干细胞疗法
  • 批准号:
    10552623
  • 财政年份:
    2022
  • 资助金额:
    $ 8.59万
  • 项目类别:
Cellular Basis of Incisor Asymmetry
门牙不对称的细胞基础
  • 批准号:
    10535917
  • 财政年份:
    2022
  • 资助金额:
    $ 8.59万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了